Pei Yang

Hunan Cancer Hospital

Papers

1

Total Citations

12

H-Index

1

About

Pei Yang is a clinical researcher specializing in head and neck oncology, with a particular focus on the treatment of oropharyngeal squamous cell carcinoma (OPSCC). Yang's work centers on optimizing therapeutic decision-making for patients with early-stage cancers of the oropharynx, an area of growing clinical importance given the rising incidence of HPV-associated oropharyngeal malignancies. Their most notable contribution, "Patient Selection for Surgery vs Radiotherapy for Early Stage Oropharyngeal Cancer" (2021), addresses one of the field's most pressing clinical questions: how to best choose between transoral robotic surgery (TORS) and intensity-modulated radiation therapy (IMRT) for patients presenting with T1-T2 N0-M0 disease. By critically examining survival and disease outcomes across both modalities, Yang's research provides clinicians with evidence-based guidance to individualize treatment strategies, ultimately aiming to preserve patient quality of life without compromising oncologic control. With 12 citations since publication, this work has begun shaping conversations in surgical oncology and radiation oncology communities. Yang's research exemplifies the modern push toward precision oncology, where treatment selection is increasingly tailored to patient-specific clinical and biological factors.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Patient Selection for Surgery vs Radiotherapy for Early Stage Oropharyngeal Cancer
12 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Hunan Cancer Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago